Clinical Trials List
Protocol NumberABSK-011-101
Completed
2019-12-01 - 2025-12-01
Phase I
Recruiting2
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chiun Hsu 無
- TSUNG-HAO LIU 無
- Chih-Hung Hsu 無
- 呂理駿 無
- Ann-Lii Cheng Division of Hematology & Oncology
- YU-YUN SHAO 無
- Ying-Chun Shen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉奕廷 無
- Li-Tzong Chen 無
- 簡世杰 無
- Nai-Jung Chiang Division of Hematology & Oncology
- 顏志傑 無
- Chien-Jui Huang 無
- 姜乃榕 無
- Shang-Yin Wu 無
- Chiu Hung Chiu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30~40 participants
-
Global
200 participants
